Families for Depression Awareness
Home
About Us
Family Profiles
Expert Profiles
Membership
Resources
Contact Us
< previous menu 1 2 next >

Treatment-resistant Depression

Scott Aaronson, M.D.

What is treatment-resistant depression?
There isn't a standard definition for treatment-resistant depression. I would define it as a depression that has failed to respond to an adequate dose of an approved psychiatric agent given for at least four to six weeks. However, I wouldn't consider a patient to be treatment resistant until the patient has failed to see results on at least two to three different medications.

It is important to remember that 35% of patients do not respond to initial treatment. So if you haven't experienced any results with one medication, this does not necessarily mean you are treatment resistant. In general, if you fail to see any improvements on an adequate dosage for four weeks, then the particular medication is not working and it is time to try a new medication.

Who typically has treatment resistant depression?
Almost everyone has a chance of becoming treatment resistant. I usually see patients that have been through several doctors and medications. Often these patients have developed a dysthymic disorder, (a chronic unhappiness) and have many physiological and psychological symptoms. They get referred to me because their doctors have run out of options.

What therapies are available for treatment-resistant depression?
There are different approaches to try. I can move a patient to a different class of medication or combine medications. I look for a response to a medication, and at least a 30% improvement.

What are the success rates?
I would say about 70% of the patients that I see respond to a medication, but it may be a partial response and not as much as I would like. So it is important to combine medication with other therapies, such as psychotherapy. Psychotherapy can help patients change their perceptions of themselves and world around them.

< previous menu 1 2 next >

© 2001 Families for Depression Awareness

Treatment-Resistant Depression
Dr. Scott Aaronson is the director of clinical research programs at the Sheppard Pratt Health System.

Send To A Friend

Free Brochure
Free E-mail Alert